Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelomonocytic, Acute × Melphalan × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 30 Multiple Myeloma 27 Myelodysplastic Syndromes 25 Precursor Cell Lymphoblastic Leukemia-Lymphoma 24 Hodgkin Disease 12 Lymphoma, Non-Hodgkin 11 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11 Lymphoma 10 Leukemia 9 Hematologic Neoplasms 9 Myeloproliferative Disorders 8 Neuroblastoma 7 Leukemia, Myelomonocytic, Chronic 7 Anemia, Refractory, with Excess of Blasts 7 Neoplasms, Plasma Cell 6 Lymphoma, Mantle-Cell 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Leukemia, Biphenotypic, Acute 6 Graft vs Host Disease 5 Burkitt Lymphoma 5 Recurrence 4 Primary Myelofibrosis 4 Melanoma 4 Lymphoma, T-Cell 4 Lymphoma, Follicular 4 Lymphoma, B-Cell, Marginal Zone 4 Leukemia, Myelomonocytic, Juvenile 4 Hematologic Diseases 4 Uveal Melanoma 3 Rhabdomyosarcoma 3

Interventions

Cytarabine 4 Idarubicin 3 Injections 2 Gemtuzumab 2 Filgrastim 2 Decitabine 2 veliparib 1 fludarabine phosphate 1 aldesleukin 1 Whole-Body Irradiation 1 Temozolomide 1 Sirolimus 1 Peripheral Blood Stem Cell Transplantation 1 Granulocyte Colony-Stimulating Factor 1 Etoposide 1 Daunorubicin 1 CPX-351 1 Busulfan 1 Bone Marrow Transplantation 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡